Genprex, Inc. (GNPX) Stock Analysis

0.23

0.00%Today

Market Cap

7.73M

Volume

1.16M

52W High

3.97

52W Low

0.20

No historical price data available

No price history data available for the selected time period.

Try selecting a different time range.

Company Overview

Genprex, Inc., a clinical-stage gene therapy company, focuses on developing therapies for patients with cancer and diabetes. Its lead product candidate is REQORSA (GPX-001) to treat non-small cell lung cancer and small cell lung cancer. The company is also developing GPX-002, a preclinical stage gene therapy for diabetes. Genprex, Inc. was incorporated in 2009 and is headquartered in Austin, Texas.

Contact Information

Website: https://www.genprex.com
Address: 3300 Bee Cave Road
Country: US

Investment Analysis & Insights

Key Investment Highlights

Market Position: Healthcare leader with 7.73M market capitalization
Trading Volume: 1.16M shares traded today
Price Range: 52-week range of $0.20 - $3.97
Exchange: Listed on NASDAQ Capital Market

Financial Metrics

P/E Ratio:-0.13

EPS:$-1.74

Beta:-0.48

Avg Volume:2.15M

Market Analysis for Genprex, Inc.

Genprex, Inc. (GNPX) operates in the Biotechnology industry within the Healthcare sector. With a current market capitalization of 7.73M, the company represents a significant player in its market. The stock is currently trading at $0.23 with a positivedaily change of 0.00%.

The company's 15 employee base and presence on the NASDAQ Capital Marketexchange position it as a Healthcare sector leader. Investors should consider the stock's P/E ratio of -0.13, beta of -0.48, and 52-week price range from $0.20 to $3.97when evaluating investment opportunities.